Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
August 8, 2008

FDA Taps Simulation Plus’ ADMET Predictor

  • FDA is licensing Simulations Plus’ ADMET Predictor™ software. It will be used by the agency’s Cardiovascular and Renal Products division. The program predicts almost 80 properties of molecules with only their molecular structure as input, including physicochemical, biopharmaceutical, metabolism, toxicity, and some activity properties, reports Ron Creeley, vp of marketing and sales.
  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.